
News|Articles|July 1, 2002
Remodulin (Treprostinil sodium injection) United therapeutics corp.
NME: Approved for all symptomatic stages of pulmonary arterial hypertension
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
National Alliance survey shows employers are leaving the ‘big 3’ for other PBMs
2
7 takeaways from the MHE webinar on PBM reform and transparency
3
Novo Nordisk's ziltivekimab falls short to reduce cardiovascular events in phase 3 trial
4
Prior authorization isn’t shrinking. Its savings are
5





















